Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance

doi:10.3748/wjg.v17.i16.2113

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 16

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3907)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

411

HTML

3162

Figures (1-4)

186

Tables (1-4)

148

Sum=3907

Apr 28, 2011 (publication date) through May 9, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 28, 2011; 17(16): 2113-2119
Published online Apr 28, 2011. doi: 10.3748/wjg.v17.i16.2113

Table 3 Correlation between antitumor response and mutation status of 21 Taiwanese with advanced gastrointestinal stromal tumor treated with sunitinib

	CR	PR	SD	PD	P	CR + PR + SD	PD	P
Exon 9 (n = 6)	0	1	2	3	0.610¹	3	3	0.344¹
Exon 11 (n = 12)	2	2	5	3		9	3
Exon 13 (n = 1)	0	0	0	1
No mutation (n = 1)	0	0	1	1
PDGFRA (n = 1)	0	1	0	0

¹Exon 9 vs exon 11. CR: Complete response; PR: Partial response; SD: Stationary disease; PD: Progression of disease; PDGFRA: Platelet derived growth factor α.

Citation: Chen YY, Yeh CN, Cheng CT, Chen TW, Rau KM, Jan YY, Chen MF. Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance. World J Gastroenterol 2011; 17(16): 2113-2119
URL: https://www.wjgnet.com/1007-9327/full/v17/i16/2113.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i16.2113